首页> 外国专利> compounds, methods for inhibiting mir-21 activity, method for decreasing collagen expression, method for treating, preventing or delaying the onset of a disease, method for treating a fibroproliferative disorder and uses of a compound.

compounds, methods for inhibiting mir-21 activity, method for decreasing collagen expression, method for treating, preventing or delaying the onset of a disease, method for treating a fibroproliferative disorder and uses of a compound.

机译:化合物,抑制mir-21活性的方法,降低胶原蛋白表达的方法,治疗,预防或延迟疾病发作的方法,治疗纤维增生性疾病的方法以及化合物的用途。

摘要

Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer.
机译:本文描述了用于抑制miR-21活性的组合物和方法。所述组合物具有某些核苷修饰模式,其产生有效的miR-21活性抑制剂。该组合物可用于抑制miR-21,也可用于治疗与miR-21异常表达有关的疾病,例如纤维化和癌症。

著录项

  • 公开/公告号BR112014026639A8

    专利类型

  • 公开/公告日2018-01-16

    原文格式PDF

  • 申请/专利权人 REGULUS THERAPEUTICS INC.;

    申请/专利号BR20141126639

  • 发明设计人 BALKRISHEN BHAT;ERIC MARCUSSON;

    申请日2013-04-24

  • 分类号A61P13/12;A61K31/712;A61P35;A61P43;C12N15/113;

  • 国家 BR

  • 入库时间 2022-08-21 12:54:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号